Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2019

Open Access 01-12-2019 | Diabetes | Research article

In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds

Authors: Gebretsadkan Hintsa Tekulu, Ephrem Mebrahtu Araya, Hayelom Gebrekirstos Mengesha

Published in: BMC Complementary Medicine and Therapies | Issue 1/2019

Login to get access

Abstract

Background

About 425 million adults had diabetes mellitus globally in 2017. Type 2 diabetes accounts for the enormous majority of diabetes cases and it is gradually growing which is predicted to increase by 48% in 2045. Imbalanced cellular carbohydrate and lipid metabolism cause an increase in postprandial blood glucose level which eventually leads to the onset and progression of type 2 diabetes mellitus. The lack of effective and safe carbohydrate hydrolyzing enzyme inhibitors contributes to the increasing prevalence. Thus, this study was targeted to assess the α-amylase inhibitory potential of isolates obtained from Aloe megalacantha Baker and Aloe monticola Reynolds, which are among the commonly used folkloric remedies for the management of diabetes mellitus.

Method

The α-amylase inhibitory effect of Aloe megalacantha Baker and Aloe monticola Reynolds were evaluated using the 3,5-dinitro salicylic acid method. 2, 2-Diphenyl-2-picrylhydrazyl free radical scavenging property was also used to test the antioxidant effect of both plants. Results were analysed using GraphPad Prism software version 8.

Results

The more polar isolates (AM1 and AG1) were possessed stronger α-amylase inhibition activity than the leaves latex and the other strains (AM2 and AG2). Leaf latex of A. megalacantha, AM1, AM2, leaf latex of A. monticola, AG1, and AG2 were found to have an IC50 value of 74.76 ± 1.98, 37.83 ± 3.31, 96.75 ± 1.98, 78.10 ± 1.88, 56.95 ± 1.88 and 64.03 ± 3.60 μg/mL, respectively (P < 0.001). The leaf latexes of A. megalacantha and A. monticola showed a significant (P < 0.001) free radical hunting property with an IC50 value of 890.1 ± 1.73 and 597.5 ± 2.02 μg/mL, respectively.

Conclusion

Hence, the outcomes of the present investigation partly justify the acclaimed use of Aloe megalacantha and Aloe monticola for the treatment of diabetes.
Literature
1.
2.
3.
Ab Hamid MR, Mustafa Z, Suradi NRM, Idris F, Abdullah M. Multi-factor of employee values: a confirmatory factor analytics (CFA) validation. Afr J Business Management. 2011;5(32):12632–40.CrossRef
4.
5.
Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98.CrossRef
6.
7.
Oboh G, Isaac AT, Akinyemi AJ, Ajani RA. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside induced lipid peroxidation in rats' pancreas by phenolic extracts of avocado pear leaves and fruit. Int J Biomed Sci. 2014;10(3):208–16.PubMedPubMedCentral
8.
9.
Cock IE. The genus Aloe: Phytochemistry and therapeutic uses including treatments for gastrointestinal conditions and chronic inflammation. Prog Drug Res. 2015;70:179–235.CrossRef
10.
Teklay A, Abera B, Giday M. An ethnobotanical study of medicinal plants used in Kilte Awulaelo district, Tigray region of Ethiopia. J Ethnobiol Ethnomed. 2013;9:01–23.CrossRef
11.
Belayneh A, Bussa NF. Ethnomedicinal plants used to treat human ailments in the prehistoric place of Harla and Dengego valleys, eastern Ethiopia. J Ethnobiol Ethnomed. 2014;10:18–25.CrossRef
12.
Araya S, Abera B, Giday M. Study of plants traditionally used in public and animal health management in Seharti Samre district, southern Tigray, Ethiopia. J Ethnobiol Ethnomed. 2015;11:1–25.CrossRef
13.
Kebede A, Ayalew S, Mesfin A, Mulualem G. Ethnobotanical investigation of traditional medicinal plants commercialized in the markets of Dire Dawa city, eastern Ethiopia. J Med Plants Stud. 2016;4:170–8.
14.
15.
Demissew S, Nordal I. Aloes and lilies of Ethiopia and Eritrea. 1st ed. Addis Ababa: Shama Books; 2010.
16.
Demissew S, Friis I, Awas T, Wilkin P, Weber O, Bachman S, Nordal I. Four new species of Aloe (Aloaceae) from Ethiopia, with notes on the ethics of describing new taxa from foreign countries. Kew Bull. 2011;66:111–21.CrossRef
17.
18.
19.
Abdissa N, Gohlke S, Frese M, Sewald N. Cytotoxic compounds from Aloe megalacantha. Molecules. 2017;22:1136–45.CrossRef
20.
21.
Geremedhin G, Bisrat D, Asres K. Isolation, characterization and in vivo antimalarial evaluation of anthrones from the leaf latex of Aloe percrassa Todaro. J Nat Rem. 2014;14:120–5.
22.
Teka T, Bisrat D, Yeshak MY, Asres K. Antimalarial activity of the chemical constituents of the leaf latex of Aloe pulcherrima Gilbert and Sebsebe. Molecules. 2016;21:1415.CrossRef
23.
Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem. 1959;31:426–8.CrossRef
24.
Braca A, De Tommasi N, Di Bari L, Pizza C, Politi M, Morelli I. Antioxidant principles from Bauhinia tarapotensis. J Nat Prod. 2001;64(7):892–5.CrossRef
25.
Dagne E, Bisrat D, Viljoen A, Wyk B. Chemistry of Aloe species. Curr Org Chem. 2000;4:1055–78.CrossRef
26.
27.
28.
29.
Manjunath K, Prakash GB, Subash KR, Tadvi NA, Manikanta M, Rao KU. Effect of Aloe vera leaf extract on blood glucose levels in alloxan induced diabetic rats. Natl J Physiol Pharm Pharmacol. 2016;6(5):471–4.CrossRef
30.
Gundidza M, Masuku S, Humphrey G, Magwa ML. Anti-diabetic activity of Aloe excelsa. Cent Afr J Med. 2005;51(11–12):115–20.PubMed
31.
32.
33.
Hu Y, Xu J, Hu Q. Evaluation of antioxidant potential of Aloe vera (Aloe barbadensis Miller) extracts. J Agri Food Chem. 2003;51(26):7788–91.CrossRef
34.
35.
Nejatzadeh-Barandozi F. Antibacterial activities and antioxidant capacityof Aloe vera. Org Med Chem Lett. 2013;3:5.CrossRef
36.
37.
Brhane GH, Gopalakrishnan VK, Hagos Z, Hiruy M, Devaki K, Chaithanya KK. Phytochemical screening and in vitro antioxidant activities of ethanolic gel extract of Aloe adigratana Reynolds. J Pharm Res. 2018;12(1):13–9.
Metadata
Title
In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds
Authors
Gebretsadkan Hintsa Tekulu
Ephrem Mebrahtu Araya
Hayelom Gebrekirstos Mengesha
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2019
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-019-2622-5

Other articles of this Issue 1/2019

BMC Complementary Medicine and Therapies 1/2019 Go to the issue

Research article

Suppression of lung inflammation by the ethanol extract of Chung-Sang and the possible role of Nrf2

Research article

Cytotoxic activity of crude extracts from Datura stramonium’s fungal endophytes against A549 lung carcinoma and UMG87 glioblastoma cell lines and LC-QTOF-MS/MS based metabolite profiling

Research article

Anti-HIV-1 protease activity of the crude extracts and isolated compounds from Auricularia polytricha

Research article

The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet

Research article

Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma

Research article

Sub-acute and acute toxicity of Ferula asafoetida and Silybum marianum formulation and effect of the formulation on delaying gastric emptying